Henriette C. Jodal is a medical doctor and PhD in the Clinical Effectiveness Research group at Department of Health Management and Health Economics at the University of Oslo and Department of Transplantation Medicine at Oslo University Hospital. Her main research topic is surveillance of individuals with adenomas (precancerous lesions of the large bowel). She is in particular interested in providing the correct care to the correct patient - based on available evidence and patient preferences.
She received Caroline Museæus Aarsvolds scholarship by the Norwegian Medical Association in 2018, and spent six months at Harvard School of Public Health and Frontier Science Foundation in Boston, US.
Today, she works as a resident in oncology at Drammen hospital and researcher at Oslo University Hospital.
- 2022 - today: Researcher, Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo and Oslo University Hospital
- 2015 - 2022: PhD Candidate, Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital
- 2019: Visiting researcher, Frontier Science Foundation and Harvard T. H. Chan School of Public Health, Boston, USA
- 2010 - 2013: Medical research student, CoE Centre for Immune Regulation, Institute of Clinical Medicine, University of Oslo
- 2022 - today: Resident in oncology, Vestre Viken Drammen hospital
- 2021 - 2022: Resident in oncology, Vestfold Hospital Trust
- 2017 - 2021: General Practitioner, Emergency Ward, City of Oslo
- 2016 - 2017: Medical Intern, Husebyskogen Medical Centre, City of Oslo
- 2015 - 2016: Medical Intern, Oslo University Hospital
- 2013 - 2014: MD Student License, Minor Trauma Room, Oslo University Hospital
- 2013: MD Student License, Psychiatric Ward, Telemark Hospital Skien
- 2015 - 2022: PhD in epidemiology, University of Oslo
- 2008 - 2015: Medical Doctor, University of Oslo
- 2010 - 2013: Medical Student Research Program, University of Oslo
- 2013: Exchange student, University of New South Wales, Sydney